CourageAS Biotherapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

CourageAS Biotherapeutics General Information

Description

Developer of therapeutics intended to transform the lives of individuals with Angelman syndrome.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • New Jersey Bioscience Center
  • 675 US Highway 1
  • North Brunswick, NJ 08902
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • New Jersey Bioscience Center
  • 675 US Highway 1
  • North Brunswick, NJ 08902
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CourageAS Biotherapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CourageAS Biotherapeutics‘s full profile, request access.

Request a free trial

CourageAS Biotherapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CourageAS Biotherapeutics‘s full profile, request access.

Request a free trial

CourageAS Biotherapeutics FAQs

  • When was CourageAS Biotherapeutics founded?

    CourageAS Biotherapeutics was founded in 2025.

  • Where is CourageAS Biotherapeutics headquartered?

    CourageAS Biotherapeutics is headquartered in North Brunswick, NJ.

  • What industry is CourageAS Biotherapeutics in?

    CourageAS Biotherapeutics’s primary industry is Drug Discovery.

  • Is CourageAS Biotherapeutics a private or public company?

    CourageAS Biotherapeutics is a Private company.

  • What is CourageAS Biotherapeutics’s current revenue?

    The current revenue for CourageAS Biotherapeutics is .

  • Who are CourageAS Biotherapeutics’s investors?

    Couragene and Foundation for Angelman Syndrome Therapeutics have invested in CourageAS Biotherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process